Diabetes and hyperglycemia in the critical care setting: Has the evidence for glycemic control vanished? (or ⋯ is going away?)

Current Diabetes Reports

Volumn 14, Issue 1, 2014, Pages

  Wagstaff, Amy E ^a   Cheung, N Wah ^b  

^a Dubbo Base Hospital   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Critical care setting; Critical illness; Diabetes; Glucose; Glycemic control; Hospital; Hyperglycemia; Intensive care

Indexed keywords

GLUCOSE; INSULIN; GLUCOSE BLOOD LEVEL;

ACUTE HEART INFARCTION; ARTICLE; CEREBROVASCULAR ACCIDENT; CRITICAL ILLNESS; DIABETES MELLITUS; GLUCOSE INFUSION; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN INFUSION; INSULIN TREATMENT; INTENSIVE CARE; PRACTICE GUIDELINE; ANALYSIS; BLOOD; GLUCOSE BLOOD LEVEL;

BLOOD GLUCOSE; CRITICAL CARE; DIABETES MELLITUS; HUMANS; HYPERGLYCEMIA;

MLCS; MLOWN;

EID: 84896719623     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-013-0444-2     Document Type: Article

References (86)

1. Finney SJ, Zekfeld C, Elia A, Evans TW. Glucose control and mortality in critical illness. JAMA. 2003;290:2041-4.
2. Bagshaw SM, Egi M, George C, Bellomo R. The ANZICS Database Management Committee: early blood glucose control and mortality in critically ill patients in Australia. Crit Care Med. 2009;37:463-70.
3. Wong V, Ross DL, Park K, Boyages S, Cheung NW. Hyperglycemia following acute myocardial infarction is a predictor of poor cardiac outcomes in the reperfusion era. Diab Res Clin Pract. 2004;64:85-91.7.
4. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction. Circulation. 2005;111:3078-86.
5. Goyal A, Mehta SR, Diaz R, et al. Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction. Circulation. 2009;120:2429-37.
6. Timmer JR, Hoekstra M, Nijsten MWN, et al. Prognostic value of admission glycosylated hemoglobin and glucose in nondiabetic patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. Circulation. 2011;124:704-11.
7. Yong M, Kaste M. Dynamic of hyperglycemia as a predictor of stroke outcome in the ECASS-II Trial. Stroke. 2008;39:2749-55.
8. Poppe AY, Majumdar SR, Jeerakathil T, et al. Admission hyperglycaemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis. Diabetes Care. 2009;32:617-22.
9. Laird AM, Miller PR, Kilgo PD, et al. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma. 2004;56:1058-62.
10. Zerr KJ, Furnary AP, Grunkemeier GL, et al. Infection in diabetics after open heart operations. Ann Thorac Surg. 1997;63:356-61.
11. Cheung NW, Napier B, Zaccaria C, Fletcher JP. Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition. Diabetes Care. 2005;28:2367-71.
12. Cheung NW, Ma G, Li S, Crampton R. The relationship between admission blood glucose levels and hospital mortality. Diabetologia. 2008;51:952-5.
13. Umpierrez GE, Isaacs SD, Bazargan N, et al. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87:978-82.
14. Dungan KM, Braithwaite SS, Preiser JC. Stress hyperglycaemia. Lancet. 2009;373:1798-07.
15. Mowat A, Baum J. Chemotaxis of polymorphonuclear leukocytes from patients with diabetes mellitus. N Engl J Med. 1971;284:621-7.
16. Bagdade J, Neilson K, Bulger R. Reversible abnormalities in phagocytic function in poorly controlled diabetic patients. Am J Med Sci. 1972;263:451-6.
17. Nielson C, Hindson D. Inhibition of polymorphonuclear leukocyte respiratory burst by elevated glucose concentration in vitro. Diabetes. 1989;38:1031-5.
18. McManus LM, Bloodworth RC, Prihoda TJ, et al. Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia. J Leukoc Biol. 2001;70:395-404.
19. Von Kanel R, Mills P, Dimsdale J. Short term hyperglycemia induces lymphopenia and lymphocyte subset redistribution. Life Sci. 2001;69:255-62.
20. Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans. Circulation. 2002;106:2067-72.
21. Wong V, McLean M, Boyages S, Cheung NW. CRP levels following acute myocardial infarction: effect of insulin infusion and tight glycemic control. Diabetes Care. 2004;27:2971-3.
22. Marfella R, Nappo F, De Angelis L, et al. Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. Diabetes Care. 2000;23:658-63.
23. Wong VW, Mardini M, Cheung NW, Mihailidou A. High-dose insulin in experimental myocardial infarction in rabbits: protection against effects of hyperglycemia. J Diab Comp. 2011;25:122-8.
24. Marfella R, D'Amico M, Di Filippo C, et al. Myocardial infarction in diabetic rats: role of hyperglycemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia. 2002;45:1172-81.
25. Parsons MW, Barber PA, Desmond PM, et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann Neurol. 2002;52:20-8.
26. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-67.
27. Van den Berghe G, Wouters P, Boullon R, et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose vs glycemic control. Crit Care Med. 2003;31:359-66.
28. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449-61.
29. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomized multi-center controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2007;33:S189.
30. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008;358:125-39.
31. Arabi YM, Ousama CD, Tamim HM, et al. Intensive vs conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med. 2008;36:3190-7.
32. De la Rosa GDC, Donado JH, Restrepo AH, et al. Strict glycaemic control in patients hospitalized in a mixed medical and surgical intensive care unit: a randomized clinical trial. Crit Care. 2008;12:R120.
33. Annane D, Cariou A, Maxime V, et al. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA. 2010;303:341-8.
34. Finfer S, Chittock DR, Su SY, et al. Intensive vs conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283-97.
35. • Finfer S, Liu B, Chittock DR, et al. Hypoglycemia and risk of death in critically ill patients. N Engl J Med. 2012;367:1108-18. This paper documented the high incidence of hypoglycemia in the NICE-SUGAR Study, and examined the relationship between hypoglycemia and mortality.
36. Cheung NW, McLean M, Wong VW. Insulin therapy for myocardial infarction. Expert Opin Pharmacother. 2006;7:2495-503.
37. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI Study): effects on mortality at 1 year. J Am Coll Cardiol. 1995;20:57-65.
38. Malmberg K. Prospective randomized study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. Br Med J. 1997;314:1512-5.
39. Malmberg K, Ryden L, Wedel H, et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J. 2005;26:650-61.
40. Cheung NW, Wong VW, McLean M. The Hyperglycemia: Intensive Insulin Infusion in Infarction (HI-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction. Diabetes Care. 2006;29:765-70.
41. Gray CS, Hildreth AJ, Sandercock PA, et al. Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: the UK Glucose Insulin in Stroke Trial (GIST-UK). Lancet Neurol. 2007;6:397-406.
42. • Middleton S, McElduff P, Ward J, et al. Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomized controlled trial. Lancet. 2011;378:1699-706. The first and only study where an intervention including glucose control resulted in improved stroke outcomes.
43. • Umpierrez GE, Smiley D, Jacobs S, et al. Randomized study of basal bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 Surgery). Diabetes Care. 2011;34:256-61. This RCT demonstrated that surgical patients with diabetes who achieve lower blood glucose levels have improved clinical outcomes.
44. Griesdale DEG, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180:821-7.
45. Ling Y, Li X, Gao X. Intensive vs conventional glucose control in critically ill patients: a meta-analysis of randomized controlled trials. Eur J Int Med. 2012;23:564-74.
46. Murad MH, Coburn JA, Coto-Yglesias F, et al. Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97:49-58.
47. Ooi YC, Dagi TF, Maltenfort M, et al. Tight glycemic control reduces infection and improves neurological outcome in critically ill neurosurgical and neurological patients. Neurosurgery. 2012;71:692-702.
48. Kramer AH, Robers DJ, Zygun DA. Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis. Critical Care. 2012;16:R203.
49. Bellolio MF, Gilmore RM, Stead LG. Insulin for glycaemic control in acute ischemic stroke. Cochrane Database of Systematic Reviews. 2011;9, CD005346. doi: 10.1002/14651858.CD005346.pub3.
50. Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU. A systematic review and meta-analysis. Chest. 2010;137:544-51.
51. Kansagara D, Fu R, Freeman M, et al. Intensive insulin therapy in hospitalized patients: a systematic review. Ann Intern Med. 2011;154:268-82.
52. Van den Berghe G, Schetz M, Vlasselaers D, et al. Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? J Clin Endocrinol Metab. 2009;94:3163-70.
53. Cheung NW. Glucose control during acute myocardial infarction. Intern Med J. 2008;38:345-8.
54. Egi M, Bellomo R, Stachowski E, et al. Hypoglycemia and outcome in critically ill patients. Mayo Clin Proc. 2010;85:217-24.
55. Cryer PE. Hypoglycemia, functional brain failure, and brain death. J Clin Invest. 2007;117:868-70.
56. Holzinger U, Warszawska J, Kitzberger R, et al. Real-time continuous glucose monitoring in critically ill patients. Diabetes Care. 2010;33:467-72.
57. American Diabetes Association: standards of medical care in diabetes - 2013. Diabetes Care. 2013;36(Suppl 1):S11-66.
58. Boyd JC, Bruns DE. Quality specifications for glucose meters: assessment by simulation modelling of errors in insulin dose. Clin Chem. 2001;47:209-14.
59. • Inoue S, Egi M, Kotani J, et al. Accuracy of blood-glucose measurements using glucose meters and arterial blood gas analyzers in critically ill adult patients: systematic review. Critical Care. 2013;17:R48. A systematic review examining the accuracy of glucose measurement methods in the ICU.
60. Risso A, Mercuri F, Quagliaro L, et al. Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture. Am J Physiol Endocrinol Metab. 2001;281:E924-30.
61. Quagliaro L, Piconi L, Assaloni R, et al. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells. The role of protein kinase C and NAD(P)H-oxidase activation. Diabetes. 2003;52:2795-804.
62. Ceriello A, Esposito K, Piconi L, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008;57:1349-54.
63. Goyal A, Mahaffey KW, Garg J, et al. Prognostic significance of the change in glucose level in the first 24 hours after acute myocardial infarction: results from the CARDINAL study. Eur Heart J. 2006;27:1289-97.
64. Su G, Mi SH, Tao H, et al. Impact of admission glycemic variability, glucose, and glycosylated hemoglobin on major adverse cardiac events after acute myocardial infarction. Diabetes Care. 2013;36:1026-32.
65. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality of critically ill patients. Anesthesiology. 2006;105:244-52.
66. Krinsley JS. Glycemic variability and mortality in critically ill patients: the impact of diabetes. J Diabetes Sci Technol. 2009;3:1292-301.
67. Krinsley JS, Preiser JC. Intensive insulin therapy to control hyperglycemia in the critically ill: a look back at the evidence shapes the challenges ahead. Crit Care. 2010;14:330.
68. Melbin LG, Malmberg K, Ryden L, et al. The relationship between glycaemic variability and cardiovascular complications in patients with acute myocardial infarction and type 2 diabetes: a report from the DIGAMI 2 trial. Eur Heart J. 2013;34:374-79.
69. Meyfroidt G, Keenan M, Wang X, et al. Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality. Crit Care Med. 2010;38:1021-9.
70. Flower O, Finfer S. Glucose control in critically ill patients. Intern Med J. 2012;42:4-6.
71. Krinsley JS. Glycemic control, diabetic status and mortality in a heterogeneous population of critically ill patients before and during the era of tight glycemic control. Semin Thorac Cardiovasc Surg. 2006;18:317-25.
72. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773-8.
73. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycaemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2000;32:2426-32.
74. Krinsley JS, Egi M, Kiss A, et al. Diabetic status and the relation of the 3 domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Crit Care. 2013;17:R37.
75. Krinsley JS, Meyfroidt G, Van den Berghe G, Egi M, Bellomo R. The impact of premorbid diabetic status on the relationship between the 3 domains of glycemic control and mortality in critically ill patients. Curr Opin Clin Nutr Metab Care. 2012;15:151-60.
76. Wong KYC, Wong VW, Ho JT, et al. High cortisol levels in hyperglycemic myocardial infarct patients signify stress hyperglycemia and predict subsequent normalization of glucose tolerance. Clin Endocrinol. 2010;72:189-95.
77. Egi M, Bellomo R, Stachowski E, French CJ, et al. Blood glucose concentration and outcome of critical illness: the impact of diabetes. Crit Care Med. 2008;36:2249-55.
78. Marik PE, Bellomo R. Stress hyperglycemia: an essential survival response! Crit Care. 2013;17:305.
79. Qaseem A, Humphrey LL, Chou R, Snow V, Shekelle P. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2011;154:260-7.
80. Klonoff DC. Intensive insulin therapy in critically ill hospitalized patients: making it safe and effective. J Diabetes Sci Technol. 2011;5:755-67.
81. Moghissi ES, Korytkowski MT, DiNardo M, et al. American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on inpatient glycemic control. Diabetes Care. 2009;32:1119-31.
82. Kushner FG, Hand M, Smith SC, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guideline on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update). Cath Cardiovcasc Intervent. 2009;74:E25-68.
83. Umpierrez GE, Hellman R, Korytkowski MT, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97:16-38.
84. Australian Diabetes Society. Australian Diabetes Society guidelines for routine Glucose control in hospital. Available at https://www.diabetessociety. com.au/documents/ADSGuidelinesforRoutineGlucoseControlinHospitalFinal2012-000. pdf. Last accessed June 30 2013.
85. Dellinger RP, Levy LL, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39:165-228.
86. Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med. 2012;40:3251-76.